OTCMKTS:PCLOF PharmaCielo (PCLOF) Stock Price, News & Analysis → This Weight Loss Company Can't Make Enough Product (From Behind the Markets) (Ad) Free PCLOF Stock Alerts $0.11 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$0.11▼$0.1150-Day Range$0.11▼$0.2252-Week Range$0.08▼$0.22Volume1,145 shsAverage Volume10,101 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get PharmaCielo alerts: Email Address Ad Behind the MarketsAre you prepared for a Chinese "invasion?"Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United StatesHere are 4 steps you can take RIGHT NOW >>> About PharmaCielo Stock (OTCMKTS:PCLOF)PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.Read More PCLOF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PCLOF Stock News HeadlinesMay 22, 2024 | benzinga.comPharmaCielo Stock (OTC:PCLOF), Quotes and News SummaryApril 10, 2024 | msn.comThis Latin American Cannabis Co. Plans To Expand In Thailand Amid Significant Shifts In Weed Regulation LandscapeApril 10, 2024 | msn.comPharmaCielo signs binding letter of intent to acquire operations in ThailandFebruary 14, 2024 | msn.comCan Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes GlobalJanuary 4, 2024 | benzinga.comCannabis Companies Partner To Provide Seed-to-Pharma Products GloballyJanuary 4, 2024 | finance.yahoo.comBenuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related ProductsNovember 30, 2023 | benzinga.comPharmaCielo Stock (OTC:PCLOF), Short Interest ReportNovember 30, 2023 | benzinga.comPharmaCielo Stock (OTC:PCLOF) Earnings Dates and Earning CallsNovember 29, 2023 | msn.comPharmaCielo GAAP EPS of -C$0.02, revenue of C$352MNovember 29, 2023 | finanznachrichten.dePharmaCielo Ltd.: PharmaCielo Announces Q3 2023 Financial ResultsNovember 29, 2023 | finance.yahoo.comPharmaCielo Announces Q3 2023 Financial ResultsNovember 8, 2023 | morningstar.comPharmaCielo Ltd Ordinary Shares PCLOFOctober 6, 2023 | finanznachrichten.dePharmaCielo Ltd.: PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private PlacementOctober 6, 2023 | finance.yahoo.comPharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private PlacementAugust 29, 2023 | benzinga.comPharmaCielo Q2 2023 Results: Revenue Drops But CEO Is Optimistic About Future GrowthAugust 29, 2023 | finance.yahoo.comPharmaCielo Announces Q2 2023 Financial ResultsJuly 13, 2023 | msn.comPharmaCielo appoints Marc Lustig as chairman and CEOJuly 11, 2023 | finance.yahoo.comPharmaCielo Announces Appointment of Marc Lustig as Chairman and CEOMay 29, 2023 | finance.yahoo.comPharmaCielo Announces Q1 2023 Financial ResultsApril 19, 2023 | finance.yahoo.comPharmaCielo Announces Strategic Partnership with CANNPRISMA to Supply EU-GMP Certified Dried Flower to the European Medicinal Cannabis MarketFebruary 24, 2023 | finance.yahoo.comPharmaCielo Ltd. (PCLOF) Stock Historical Prices & Data - Yahoo FinanceFebruary 2, 2023 | finance.yahoo.comPharmaCielo Announces Continued Progress on Efficiency Initiatives to Accelerate Profitability and Intention to Amend Warrant TermsJanuary 30, 2023 | finance.yahoo.comPharmaCielo Receives First Commercial Purchase Order from Ease Labs Pharma - Proprietary API a Key Ingredient in Recently Approved Product for Brazilian MarketDecember 5, 2022 | finance.yahoo.comPharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in MoroccoNovember 22, 2022 | finance.yahoo.comPharmaCielo Announces TSX Venture Exchange Approval of Warrant ExtensionSee More Headlines Receive PCLOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PharmaCielo and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:PCLOF CUSIPN/A CIKN/A Webwww.pharmacielo.com Phone(416) 562-3220FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Chairman & CEO Comp: $41.87kMr. Ian D. Atacan B.Sc.C.M.A., C.P.A., M.B.A., CFO, Corporate Secretary & DirectorMr. Andres Felipe BoteroChief Operating OfficerDr. Decio Rabelo de Castro FilhoChief Medical OfficerKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors PCLOF Stock Analysis - Frequently Asked Questions How have PCLOF shares performed in 2024? PharmaCielo's stock was trading at $0.1290 at the beginning of 2024. Since then, PCLOF stock has decreased by 13.3% and is now trading at $0.1118. View the best growth stocks for 2024 here. Are investors shorting PharmaCielo? PharmaCielo saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 34,000 shares, an increase of 771.8% from the April 30th total of 3,900 shares. Based on an average daily volume of 16,800 shares, the days-to-cover ratio is presently 2.0 days. View PharmaCielo's Short Interest. How do I buy shares of PharmaCielo? Shares of PCLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PCLOF) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PharmaCielo Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PharmaCielo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.